Patent · US Active

Method for treating myocardial ischemia

US8343921B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Shanghai Bajiayi Pharmaceutical Science and Technology Co. Ltd. · CN

Inventors

Yaocheng Rui · Shanghai, CN
Tiejun Li · Beijing, CN
Pengyuan Yang · Beijing, CN
Yuefan Zhang · Shanghai, CN

Key dates

Filing date	Jan 23, 2012
Grant date	Jan 1, 2013
Priority date	—
Expiry date	Jan 23, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Use of polypeptide micromolecule MLIF in preparing medicine for preventing and treating myocardial ischmia, where amino acid sequence of the polypeptide micromolecule MLIF is Met-Gln-Cys-Asn-Ser (SEQ ID NO:1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.